XML 67 R9.htm IDEA: XBRL DOCUMENT v3.19.3
Stock Options
9 Months Ended
Sep. 30, 2019
Share-based Payment Arrangement [Abstract]  
Stock Options

Note 3. Stock Options

 

The following table summarizes stock option activity for the period ended September 30, 2019:

 

  

Number of

Options

 

Weighted Average

Exercise Price ($)

 

Weighted Average

Remaining Contractual Term (years)

 

Aggregate

Intrinsic Value ($)

Outstanding at December 31, 2018    317,500    3.41           
Outstanding at September 30, 2019    317,500    3.41    6.93    53,450 
Exercisable at September 30, 2019    317,500    3.41    6.93    53,450 

 

There were no options granted during the nine months ended September 30, 2019.

 

The share-based compensation cost resulting from stock option grants, including those previously granted and vesting over time is expensed ratably over the respective vesting periods. During the three months ended September 30, 2019 and 2018, the Company recognized $0 and $371, respectively, in share-based compensation related to stock options. During the nine months ended September 30, 2019 and 2018, the Company recognized $832 and $170,517, respectively, in share-based compensation related to stock options. As of September 30, 2019, the Company had no unrecognized compensation cost related to unvested stock options. Stock-based compensation has been included in the unaudited consolidated statement of operations as follows:

 

   Three Months Ended September 30,  Nine Months Ended September 30,
   2019  2018  2019  2018
Research and development  $-   $-   $-   $27,966 
General and administrative   -    371    832    142,551 
Total  $-   $371   $832   $170,517 

 

The following table summarizes information about stock options outstanding and exercisable at September 30, 2019:

 

   Stock Options Outstanding  Stock Options Exercisable
Range of Exercise Prices 

Number of Shares

Subject to Outstanding Options

 

Weighted Average

Contractual Life (years)

 

Weighted Average

Exercise Price

 

Number of Shares

Subject to Options Exercise

 

Weighted Average

Remaining Contractual Life (years)

 

Weighted Average

Exercise Price

1.05    55,000    4.50    1.05    55,000    4.50    1.05 
1.25    7,500    5.71    1.25    7,500    5.71    1.25 
1.34    7,500    5.75    1.34    7,500    5.75    1.34 
1.70    7,500    6.04    1.70    7,500    6.04    1.70 
2.28    7,500    6.81    2.28    7,500    6.81    2.28 
4.20    232,500    7.62    4.20    232,500    7.62    4.20 
Total    317,500    6.93   $3.41    317,500    6.93   $3.41